Advances In Genomics, Molecular Biology Help Make Case To Stop Calling Some Low-Risk Tumors “Cancer,” Authors Of Review Say.

MedPage Today (8/17, Bankhead) reported that “recent advances in genomics and molecular biology have helped make a case to stop calling certain low-risk tumors ‘cancer,’ authors of a review of the issue concluded.” MedPage Today added, “Multiple studies...